Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms

The role of β-lactamases in reduced susceptibility or resistance to cefiderocol has been supported by recent reports. The purpose of this study was to investigate the in vitro impact of clinically available β-lactamase inhibitors on cefiderocol activity against characterized carbapenemase-producing...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianco, Gabriele, Gaibani, Paolo, Comini, Sara, Boattini, Matteo, Banche, Giuliana, Costa, Cristina, Cavallo, Rossana, Nordmann, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774952/
https://www.ncbi.nlm.nih.gov/pubmed/36551337
http://dx.doi.org/10.3390/antibiotics11121681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774952/
https://www.ncbi.nlm.nih.gov/pubmed/36551337
http://dx.doi.org/10.3390/antibiotics11121681

Ejemplares similares